1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021;71(3):209-249. https://doi.org/10.3322/caac.21660
2. Si W, Shen J, Zheng H, Fan W. The role and mechanisms of action of microRNAs in cancer drug resistance. Clin. Epigenetics. 2019;11(1):25. https://doi.org/10.1186/s13148-018-0587-8
3. Bogachev SS, Proskurina AS, Gvozdeva TS, Potter EA, Dolgova EV, Orishchenko KE, Nikolin VP, Popova NA, Chernykh E R, Ostanin AA, Leplina OYu, Varaksin NA, Ryabicheva TG, Dvornichenko VV, Ponomarenko DM, Sidorov SV. The results of phase II clinical trials of the drug Panagen and data on the 5-year non-return survival of the patients involved in the study. Ros. Bioter. Zh. 2016;15(1):13-14. Russian.
4. Proskurina AS, Alyamkina EA, Dolgova EV, Nikolin VP, Popova NA, Gvozdeva TS, Orishchenko KE, Sidorov SV, Chernykh ER, Ostanin AA, Leplina OYu, Dvornichenko VV, Ponomarenko DM, Soldatova GS, Varaksin NA, Ryabicheva TG, Zagrebelnij SN, Rogachev VA, Bogachev SS, Shurdov MA. Leykostimulatory and antitumor effect of the human double-stranded DNA preparation “Panagen” in experiments and clinical trials. I. Leykostimulatory and antitumor effect of the preparation “Panagen” in experiments. Vestn. Novosib. Gos. Univ. Ser. Biol. Klin. Med. 2013;11(4):67-82. Russian.
5. Bencivenga D, Stampone E, Roberti D, Della Ragione F, Borriello A. p27Kip1, an intrinsically unstructured protein with scaffold properties. Cells. 2021;10(9):2254. https://doi.org/10.3390/cells10092254.